86649-57-2 Usage
Description
(PYRIDIN-3-YLOXY)-ACETIC ACID, also known as 3-Pyridyloxyacetic acid, is an organic compound with the chemical formula C7H7NO3. It is characterized by the presence of a pyridine ring and an acetic acid group, which gives it unique chemical properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(PYRIDIN-3-YLOXY)-ACETIC ACID is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique chemical structure allows it to serve as a building block for the development of new pharmaceutical compounds with potential therapeutic benefits.
Used in Fine Chemicals Industry:
(PYRIDIN-3-YLOXY)-ACETIC ACID is used as a raw material for the synthesis of fine chemicals. Its versatile chemical properties make it suitable for the production of specialty chemicals used in various applications, such as fragrances, dyes, and other high-value products.
Used in Organic Intermediates Industry:
(PYRIDIN-3-YLOXY)-ACETIC ACID is used as an organic intermediate in the synthesis of various organic compounds. Its presence in the molecular structure of other organic molecules can impart specific properties, making it a valuable component in the development of new organic materials and compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 86649-57-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,6,4 and 9 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 86649-57:
(7*8)+(6*6)+(5*6)+(4*4)+(3*9)+(2*5)+(1*7)=182
182 % 10 = 2
So 86649-57-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H7NO3/c9-7(10)5-11-6-2-1-3-8-4-6/h1-4H,5H2,(H,9,10)
86649-57-2Relevant articles and documents
ORGANIC COMPOUNDS
-
Page/Page column 78, (2009/09/28)
The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The preferred compounds (which can also be present as salts) have the formula I wherein R1, R2, T, R3 and R4 are as defined in the specification.